The occurrence of acute brain lesions was lower with a transseptal puncture than with a conventional retrograde aortic approach in patients undergoing left ventricular catheter ablation, with no ...

LEXINGTON, S.C., Sept. 9, 2026 /PRNewswire/ -- ElectroWire Medical, developer of the FDA-cleared LightningWire™ Transseptal Puncture System, today announced the successful completion of its first ...

Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA.

LEXINGTON, S.C., July 15, 2026 /PRNewswire/ -- ElectroWire Medical announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its LightningWireTM Transseptal Puncture ...

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has ...

Protaryx Medical has received the US Food and Drug Administration (FDA) 510(k) clearance to market its proprietary transseptal puncture device. The development supports Protaryx Medical’s efforts to ...

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...

Protaryx Medical, an innovative medical device company developing differentiated access solutions for minimally invasive left-heart procedures, today announced the successful completion of the first U ...